Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Immuno-modulatory Properties of a Quinolin-2-(1H)-on-3-carboxamide Derivative: Relevance in Multiple Sclerosis.
Fumaric acid esters prevent the NLRP3 inflammasome-mediated and ATP-triggered pyroptosis of differentiated THP-1 cells.
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Avonex drug warning letter, severe hypatic injury
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
Neuro-Immune Interactions at Barrier Surfaces.
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.
Gordon Research Conference on Notch Signaling in Development, Regeneration & Disease
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
UCSF Seminar: "Imaging spinal cord gray matter atrophy in MS using SF-SIGMA. Is neuronal loss a key mediator of MS disability?"
Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment.
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
Biogen slips as FDA extends review of MS drug
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
Multiple sclerosis prevalence in the United States commercially insured population.
BRIEF: Teva files for Copaxone-Laquinimod patent

Pages